The Epidemiology of Cardiovascular Disease

Cardiovascular Risk Management

Volumn , Issue , 2009, Pages 1-7

  Hobbs, F D Richard ^a   Hoes, A W ^b   Cowie, M R ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Calculating cardiovascular risk; Cardiovascular disease (CVD) becoming global health challenge; Cardiovascular risk management; Epidemiology of cardiovascular disease; EUROACTION first pan European project to raise standards of preventive cardiology in Europe; Guidelines for cardiovascular risk management; INTERHEART study confirming nine potentially modifiable risk factors; Risk factors for cardiovascular disease; Successful implementation of risk reducing strategies remains patchy

Indexed keywords

EID: 84890002398     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303353.ch1     Document Type: Chapter

References (30)

1. Murray CJ, Lopez AD. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA,Harvard School of Public Health (Global Burden of Disease and Injury Series, vol. I) 1996.
2. Framingham Heart Study. Available at http://www.framinghamheartstudy. org/about/index.html (Accessed October 2007).
3. Seven Countries Study. Available at http://www.epi.umn.edu/research/7countries/overview.shtm (Accessed October 2007).
4. Tibblin G. High blood pressure in men aged 50. A population study of men born in 1913. Acta Med Scand. 1967; 470(SUPPL): 1-84
5. Marmot MG, Shipley MJ, Rose G. Inequalities in death-specific explanations of a general pattern? Lancet. 1984; 1(8384): 1003-6.
6. Assmann G. Calculating global risk: The key to intervention. Eur Heart J Suppl. 2005; 7(SUPPL F): F9-F14.
7. MONICA Study. Available at http://www.ktl.fi/monica/index.html (Accessed October 2007).
8. The Cardiovascular Health Study. Available at http://www.chs-nhlbi.org/(Accessed October 2007).
9. The Rotterdam Study. Available at http://www.epib.nl/ergo.htm (Accessed October 2007).
10. Yusuf S, Hawken S, Ounpuu S, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364: 937-52.
11. Rosengren A, Hawken S, Ounpuu S, et al., For the INTERHEART investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 953-62.
12. International Obesity Task Force. EU platform on diet, physical activity and health. March 2005. Available at: http://www.iotf.org/ media/euobesity3.pdf (Accessed October 2007).
13. Koek HL, Grobbee DE, Bots ML. Trends in cardiovascular morbidity and mortality in the Netherlands, 1980-2000. Ned Tijdschr Geneeskd. 2004; 148(1): 27-32.
14. Stewart S, MacIntyre K, MacLeod MM, et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J. 2001; 22: 209-17.
15. Mosterd A, Reitsma JB, Grobbee DE. Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980-1999: The end of an epidemic? Heart. 2002; 87: 75-6.
16. Epstein FH. Cardiovascular disease epidemiology. A journey from the past into the future. Circulation. 1996; 93: 1755-64.
17. Heart disease and stroke statistics-2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 117: e25-e146.
18. Petersen S, Peto V, Scarborough P, Rayner M. Coronary Heart Disease Statistics. London, BHF, 2005. Available at http://www.heartstats.org/datapage.asp?id=5340.
19. Hennekens CH. Increasing burden of cardiovascular disease: Current knowledge and future directions for research on risk factors. Circulation. 1998; 97: 1095-102.
20. ATP III Final Report: II. Rationale for intervention. Circulation. 2002; 106: 3163-223.
21. Sleight P, Pouleur H, Zannad F. Benefits, challenges and registerability of the polypill. Eur Heart J. 2006; 27(14): 1651-6.
22. Ian Graham, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph Herrmann-Lingen, Arno Hoes, Steve Humphries, Mike Knapton, Joep Perk, Silia G. Priori, Kalevi Pyorala, Zeljko Reiner, Luis Ruilope, Susana Sans-Menendez, Wilma Scholte op Reimer, Peter Weissberg, David Wood, John Yarnell, Jose Luis Zamorano. European guidelines on cardiovascular disease Prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur Heart J. 2007; 28: 2375-2414.
23. Broedl UC, Geiss H-C, Parhofer KG. Comparison of current guidelines for primary prevention of coronary disease. J Gen Intern Med. 2003; 18: 190-5.
24. Cullen P, Schulte H, Assmann G. The Münster Heart Study (PROCAM): Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation. 1997; 96: 2128-36.
25. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003; 24(11): 987-1003.
26. Graham IM. Guidelines on cardiovascular disease prevention in clinical practice: The European perspective. Curr Opin Cardiol. 2005; 20(5): 430-9.
27. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001; 22: 554-72.
28. EUROASPIRE I and II Groups. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. Lancet. 2001; 357: 995-1001.
29. Nainggolan L. EUROASPIRE uninspiring: Obesity and smoking wipe out any gains. Heartwire, 4 September 2007. Available at http://www.medscape.com/viewarticle/562377 (Accessed October 2007).
30. Clappers N, Verheught FWA. Hotline sessions of the 28th European Congress of Cardiology/World Congress of Cardiology 2006. Eur Heart J. 2006; 27(23): 2896-9.